Number of the records: 1  

Dendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Final analysis of phase II, open label, randomized, multicenter trial

  1. 1.
    SYSNO ASEP0506302
    Document TypeA - Abstract
    R&D Document TypeThe record was not marked in the RIV
    R&D Document TypeNení vybrán druh dokumentu
    TitleDendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Final analysis of phase II, open label, randomized, multicenter trial
    Author(s) Havel, L. (CZ)
    Kolek, V. (CZ)
    Pešek, M. (CZ)
    Černovská, M. (CZ)
    Bartůňková, J. (CZ)
    Spíšek, R. (CZ)
    Pecen, Ladislav (UIVT-O) RID, SAI, ORCID
    Krasnopolskaya, I. (CZ)
    Zemanová, M. (CZ)
    Source TitleJournal of Clinical Oncology - ISSN 0732-183X
    Roč. 37, suppl (2019), s. 9039-9039
    Languageeng - English
    WorkplaceInstitute of Computer Science
    ContactTereza Šírová, sirova@cs.cas.cz, Tel.: 266 053 800
    Year of Publishing2020
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.